PATN:NASDAQPacer Nasdaq International Patent Leaders ETF Analysis
Data as of 2026-04-23 - not real-time
$31.57
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
PATN is trading at $31.57, just below its calculated resistance of $32.03 and comfortably above the support level of $26.68. The 20‑day SMA ($29.99) sits just under the 50‑day SMA ($30.09), while the 200‑day SMA ($27.25) is well below the current price, indicating a short‑term upward bias. Momentum metrics are supportive: the RSI is at 61.7, suggesting the ETF is not yet overbought, and the MACD line ($0.64) sits above its signal ($0.44), generating a bullish signal. However, the 30‑day volatility is high at ~33% and the fund’s beta of 1.16 points to amplified price swings relative to the market. Investor sentiment is extremely greedy (Fear‑Greed Index 85.98), the expense ratio is modest at 0.65%, and the dividend yield of 2.2% adds a modest income component.
Risk considerations include the fund’s relatively small asset base ($62.7 M) and a neutral overall trend despite increasing volume. Tracking error is effectively zero and there is no premium/discount, which limits tracking risk. Liquidity is moderate, with average 10‑day volume (~41k) exceeding today’s volume (~24k), while currency exposure is inherent given its foreign large‑blend mandate. These factors together suggest a cautiously optimistic outlook, with short‑term caution near resistance and longer‑term confidence in the patent‑leader theme.
Risk considerations include the fund’s relatively small asset base ($62.7 M) and a neutral overall trend despite increasing volume. Tracking error is effectively zero and there is no premium/discount, which limits tracking risk. Liquidity is moderate, with average 10‑day volume (~41k) exceeding today’s volume (~24k), while currency exposure is inherent given its foreign large‑blend mandate. These factors together suggest a cautiously optimistic outlook, with short‑term caution near resistance and longer‑term confidence in the patent‑leader theme.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price approaching resistance at $32.03
- RSI at 61.7 indicates moderate overbought pressure
- high 30‑day volatility (~33%)
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- bullish MACD crossover confirms upward momentum
- dividend yield of 2.2% adds income appeal
- exposure to globally diversified patent‑driven innovators
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- thematic growth potential as patented technologies mature
- zero tracking error and no premium/discount ensure index fidelity
- long‑run demand for intellectual property supports upside
Key Metrics & Analysis
Fund Metrics
Expense Ratio0.65%
AUM$62.7M
Inception Date2024-09-16
Avg Daily Volume41,280
Premium/Discount0.00%
Tracking Error0.00%
Dividend Yield2.20%
Technical Analysis
TrendNeutral
RSI61.7
Support$26.68
Resistance$32.03
MA 20$30.00
MA 50$30.09
MA 200$27.25
MACDBullish
VolumeIncreasing
Fear & Greed Index85.98
Risk Assessment
Beta1.16
Volatility32.69%
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
PCMM
BondBloxx Private Credit CLO ETF
ETFPBRG
Leverage Shares 2X Long PBR Daily ETF
ETFPBQQ
PGIM Laddered Nasdaq-100 Buffer 12 ETF
ETFPBPH
Portfolio Building Block World Pharma and Biotech Index ETF
ETFPBOG
Portfolio Building Block Integrated Oil and Gas and Exploration and Production Index ETF
ETFPBEU
Portfolio Building Block European Banks Index ETF
ETFThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.